Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EAU 2023 | The urological history of chemotherapy for testis tumors in Europe

Juan Gómez Rivas • 16 Mar 2023
EAU 2023
Genitourinary Cancer Testicular Cancer Bleomycin Cisplatin Etoposide

Juan Gómez Rivas, MD, PhD, Clínico San Carlos University Hospital, Madrid, Spain, provides an overview of the urological history in Europe of chemotherapy for testis tumors. This interview took place at the EAU congress in Milan, Italy.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Juan Gómez Rivas

5:22
2nd PIONEER Studyathon: which patients benefit most from the different treatment options for mHSPC?
Juan Gómez Rivas • 16 Mar 2023
2:26
Managing biochemical relapse after radical prostatectomy
Juan Gómez Rivas • 16 Mar 2023
1:52
Active surveillance for Gleason grade 2 prostate cancer
Juan Gómez Rivas • 16 Mar 2023
5:41
Diagnosing and treating castration resistant prostate cancer
Juan Gómez Rivas • 16 Mar 2023

Related Videos

4:12
PETRA: saruparib in solid tumors with BRCA1/2, PALB2 or RAD51C/D mutations
Timothy Yap • 7 Apr 2024
0:45
SYNC-T combination immunotherapy in mCRPC
George Prendergast • 8 Apr 2024
0:40
PSMA PET findings in 225AC-J591-treated patients with mCRPC
Andres Ricaurte-Fajardo • 9 Apr 2024
0:45
Should radioligand therapies be used in earlier settings in prostate cancer?
Andres Ricaurte-Fajardo • 9 Apr 2024
The content of VJOncology is intended for healthcare professionals